# Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib

> **NCT01539655** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 34 (actual)

## Conditions studied

- Medullary Thyroid Cancer

## Interventions

- **DRUG:** vandetanib
- **DRUG:** omeprazole
- **DRUG:** ranitidine

## Key facts

- **NCT ID:** NCT01539655
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01539655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01539655, "Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01539655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*